Collectively, it appears that the downregulation of Flot-2 weakened the expression of MMPs by inactivating NF-κB signaling, which subsequently decreased the migratory capacity of NPC cells. The gene discussed is FLOT2; the disease is nasopharyngeal carcinoma.